I do not know whether you or Biotime is creating the following quote that IMO is misleading to any uninformed investor here:
>>>BioTime recent approach will allow it[who is "it"?] to legally sidestep the FDA and flood the market[what and where is that market?] with their products licensed[what license are you talking about, and where is that license effective?] under ACT patent<<<
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.